A process for preparing Form II crystals of clarithromycin is provided
comprising (a) treating clarithromycin with a carboxylic acid in an
organic solvent to provide a clarithromycin acid salt; and, (b) heating
the clarithromycin acid salt at a temperature capable of providing Form
II crystals of clarithromycin.